1. Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review

   • Slobodan M. Janković
   • Snežana V. Janković

   Review Article 21 February 2022 Pages: 291 - 308

   

2. Pharmacokinetics, Tolerability, Safety, and Immunogenicity of LY01008 and Bevacizumab (Avastin®) in Healthy Chinese Subjects

   • Lijun Xie
   • Ying Zhu
   • Feng Shao

   Original Research Article 03 February 2022 Pages: 309 - 317

   

3. Radiation Effects on Methamphetamine Pharmacokinetics and Pharmacodynamics in Rats

   • Mitchell R. McGill
   • David L. Findley
   • Michael D. Hambuchen

   Original Research Article 08 February 2022 Pages: 319 - 330

   

4. Effects and Mechanism of Action of Panax notoginseng Saponins on the Pharmacokinetics of Warfarin

   • Jiafen Qian
   • Wenjun Chen
   • Jinhua Zhang

   Original Research Article 09 February 2022 Pages: 331 - 342

   

5. Correction to: Effects and Mechanism of Action of Panax notoginseng Saponins on the Pharmacokinetics of Warfarin

   • Jiafen Qian
   • Wenjun Chen
   • Jinhua Zhang

   Correction 22 February 2022 Pages: 343 - 343

6. The Effects of AT-533 and AT-533 gel on Liver Cytochrome P450 Enzymes in Rats

   • Yanting Wu
   • Menghe Li
   • Yifei Wang

   Original Research Article 09 February 2022 Pages: 345 - 352

   

7. Prediction of Drug–Drug Interaction Between Dabrafenib and Irinotecan via UGT1A1-Mediated Glucuronidation

   • Zhe Wang
   • Xiaoyu Wang
   • Yong Liu

   Original Research Article 11 February 2022 Pages: 353 - 361

   

8. Predicting the Drug Clearance Pathway with Structural Descriptors

   • Navid Kaboudi
   • Ali Shayanfar

   Original Research Article 11 February 2022 Pages: 363 - 369

   

9. Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT₄ Receptor Agonist

   • Sandeepraj Pusalkar
   • Swapan K. Chowdhury
   • Diane Ramsden

   Original Research Article Open access 14 February 2022 Pages: 371 - 386

   

10. Population Pharmacokinetic Model for Tramadol and O-desmethyltramadol in Older Patients

    • Aymen A. Al-Qurain
    • Richard N. Upton
    • Michael D. Wiese

    Original Research Article Open access 15 February 2022 Pages: 387 - 402

    

11. In Silico Prediction of Pharmacokinetic Profile for Human Oral Drug Candidates Which Lack Clinical Pharmacokinetic Experiment Data

    • Jingchen Zhai
    • Beihong Ji
    • Junmei Wang

    Original Research Article 16 February 2022 Pages: 403 - 417

    

12. Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals

    • Xiaoxing Wang
    • Martin E. Dowty
    • Bimal K. Malhotra

    Original Research Article Open access 28 February 2022 Pages: 419 - 429

    

13. Inhibition of Cytochrome P450s by Strobilanthes crispus Sub-Fraction (F3): Implication for Herb–Drug Interaction

    • Ya Fen Yong
    • Mervyn Wing On Liew
    • Nik Soriani Yaacob

    Short Communication 11 February 2022 Pages: 431 - 440

    

14. Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

    • Swan Lin
    • Jason Gong
    • Yazdi K. Pithavala

    Correction Open access 08 March 2022 Pages: 441 - 441